Literature DB >> 10521735

Antibiotic use in pregnancy and drug-resistant infant sepsis.

B M Mercer1, T L Carr, D D Beazley, D T Crouse, B M Sibai.   

Abstract

OBJECTIVE: We sought to evaluate the effect of antepartum and intrapartum antibiotic use on antimicrobial-resistant neonatal sepsis. STUDY
DESIGN: We analyzed perinatal outcomes for 8474 pregnancies (8593 live births) delivered at 6 hospitals. Data were collected regarding maternal antibiotic use and perinatal course, neonatal cultures, and outcomes. The diagnosis of confirmed neonatal sepsis required at least one positive blood or cerebrospinal fluid culture. Neonatal cultures were evaluated on the basis of the occurrence and timing of maternal antibiotic exposure.
RESULTS: There were 96 neonates with confirmed sepsis (11.2/1000 live births). Sepsis was 19.3-fold more common after preterm birth (57 vs 3. 1/1000; P <.001), with 76% of septic infants being delivered preterm. Forty-five percent of pathogens were ampicillin resistant. Ampicillin resistance increased with preterm birth (50% vs 26%; P =. 04), antepartum antibiotics (57% vs 34%; P =.03), intrapartum antibiotics (55% vs 28%; P <.01), and any prenatal antibiotic exposure (52% vs 22%; P =.01). Infection with an organism resistant to at least one maternal antibiotic was more common with intrapartum antibiotic exposure than with antepartum exposure only (57% vs 17%; P =.01). Regarding early-onset sepsis (n = 55), ampicillin resistance was more common with intrapartum antibiotics (50% vs 16%; P <.01), and resistance to at least one maternally administered antibiotic was more frequent with intrapartum exposure (56.7% vs 0%; P <.01).
CONCLUSIONS: Maternal antibiotic treatment is associated with neonatal sepsis by organisms resistant to ampicillin and to maternally administered antibiotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521735     DOI: 10.1016/s0002-9378(99)70307-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

2.  Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

3.  Persistent bacteremia in rabbit fetuses despite maternal antibiotic therapy in a novel intrauterine-infection model.

Authors:  C Gras-Le Guen; T Debillon; C Toquet; A Jarry; N Winer; C Jacqueline; M F Kergueris; E Bingen; J C Roze; G Potel; D Bugnon
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.

Authors:  George Kafulafula; Anthony Mwatha; Ying Qing Chen; Said Aboud; Francis Martinson; Irving Hoffman; Wafaie Fawzi; Jennifer S Read; Megan Valentine; Kasonde Mwinga; Robert Goldenberg; Taha E Taha
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

5.  Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants.

Authors:  Françoise Jauréguy; Mathieu Carton; Pierre Panel; Pierre Foucaud; Marie-José Butel; Florence Doucet-Populaire
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.

Authors:  Gerald Konrad; Alan Katz
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

8.  Prevention of neonatal group B streptococcal infection: approaches of physicians in Winnipeg, Man.

Authors:  Gerald Konrad; Susan Hauch; Christy Pylypjuk
Journal:  Can Fam Physician       Date:  2007-02       Impact factor: 3.275

9.  Multidrug resistant neonatal sepsis in Peshawar, Pakistan.

Authors:  S Rahman; A Hameed; M T Roghani; Z Ullah
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

10.  Antibiotic Use Without Indication During Delivery Hospitalizations in the United States.

Authors:  Maria Andrikopoulou; Yongmei Huang; Cassandra R Duffy; Conrad N Stern-Ascher; Jason D Wright; Dena Goffman; Mary E DʼAlton; Alexander M Friedman
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.